论文部分内容阅读
研究泰特对肝硬化患者抗氧化能力的影响。选择 6 0例肝硬化患者 ,分别使用泰特及肌苷治疗 ,观测治疗前后红细胞谷胱甘肽及丙二醛的含量变化。结果 :肝硬化组谷胱甘肽含量比正常组显著降低 ,丙二醛含量显著升高 ;治疗后谷胱甘肽含量明显上升 ,丙二醛含量明显下降 ,且二治疗组间谷胱甘肽含量有显著差异 ,而丙二醛含量无差异。结论 :肝硬化患者抗氧化能力降低 ,泰特能提高肝硬化患者抗氧化能力
To study the effect of Tate on the anti-oxidative capacity of patients with cirrhosis. Totally 60 patients with cirrhosis were selected and treated with Tate and Inosine respectively. The changes of glutathione and malondialdehyde were observed before and after treatment. Results: The content of glutathione in liver cirrhosis group was significantly lower than that in normal group, and the content of malondialdehyde was significantly increased. After treatment, the content of glutathione increased obviously and the content of malondialdehyde decreased obviously. And glutathione Significantly different content, while the content of malondialdehyde no difference. Conclusion: The anti-oxidation ability of patients with liver cirrhosis is reduced, and Tate can improve the anti-oxidation ability of patients with liver cirrhosis